Phosphorylated histone H3, Ki-67, p21, fatty acid synthase, and cleaved caspase-3 expression in benign and atypical granular cell tumors

Archives of Pathology and Laboratory Medicine

Volumn 131, Issue 1, 2007, Pages 57-64

  Kapur, Payal ^a   Rakheja, Dinesh ^a,b   Balani, Jyoti P ^c   Roy, Lonnie C ^b   Amirkhan, Robin H ^a   Hoang, Mai P ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b CHILDREN S MEDICAL CENTER   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; FATTY ACID SYNTHASE; HISTONE H3; KI 67 ANTIGEN; PHOSPHOPROTEIN; PROTEIN P21;

ADULT; AGED; BENIGN TUMOR; CALCULATION; CELL DEATH; CELL PROLIFERATION; CLINICAL ARTICLE; FEMALE; GRANULAR CELL TUMOR; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; METASTASIS; MITOSIS RATE; NUCLEOLUS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVIEW; SCORING SYSTEM; STANDARD; TUMOR CLASSIFICATION;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CASPASE 3; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DIAGNOSIS, DIFFERENTIAL; FATTY ACID SYNTHETASE COMPLEX; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GRANULAR CELL TUMOR; HISTONES; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MIDDLE AGED; MITOSIS; NECROSIS; PHOSPHORYLATION; RETROSPECTIVE STUDIES; SOFT TISSUE NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 33846599193     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Review

References (21)

1. Abrikossoff A. Uber Myome, ausgehend von der quergestreiften wilulkrlichen Muskulatur. Virchows Arch Pathol Anat Physiol. 1926;260:215-233.
2. Fisher ER, Wechsler H. Granular cell myoblastoma-a misnomer: electron microscopic and histochemical evidence concerning its Schwann cell derivation and nature (granular cell schwannoma). Cancer. 1962;15:936-954.
3. Weiss SW, Goldblum JR. Enzinger and Weiss's Soft Tissue Tumors. 4th ed. St Louis, Mo: Mosby; 2001:1178-1187.
4. Steffansson K, Wollmann RL. S100 protein in granular cell tumors. Cancer. 1982;49:1834-1838.
5. Fanburg-Smith JC, Meis-Kindblom JM, Fante R, Kindblom LG. Malignant granular cell tumor of soft tissue: diagnostic criteria and clinicopathologic correlation. Am J Surg Pathol. 1998;22:779-794.
6. Jardines L, Cheung L, LiVolsi V, Hendrickson S, Brooks JJ. Malignant granular cell tumors: report of a case and review of the literature. Surgery. 1994;116:49-54.
7. Simsir A, Osborne BM, Greenebaum E. Malignant granular cell tumor: a case report and review of the recent literature. Hum Pathol. 1996;27:853-858.
8. Cruz-Mojarrieta J, Navarro S, Gomez-Cabrera E, et al. Malignant granular cell tumor of soft tissues: a study of two new cases. Int J Surg Pathol. 2001;9: 255-259.
9. Chrysomali E, Nikitakis NG, Tosios K, Sauk JJ, Papanicolaou SI. Immunohistochemical evaluation of cell proliferation antigen Ki-67 and apoptosis-related proteins Bcl-2 and caspase-3 in oral granular cell tumor. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003;96:566-572.
10. Le BH, Boyer PJ, Lewis JE, Kapadia SB. Granular cell tumor, immunohistochemical assessment of inhibin-alpha, protein gene product 9.5, S100 protein, CD68, and Ki-67 proliferate index with clinical correlation. Arch Pathol Lab Med. 2004;128:771-775.
11. Lassaletta L, Alonso S, Ballestin C, Martinez-Tello FJ, Alvarez-Vicent JJ. Immunoreactivity in granular cell tumours of the larynx. Auris Nasus Larynx. 1999;26:305-310.
12. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol. 1984;133:1710-1715.
13. Yu J, Zhang L. The transcriptional targets of p53 in apoptosis control. Biochem Biophys Res Commun. 2005;331:851-858.
14. Gurley LR, D'Anna JA, Barham SS, Deaven LL, Tobey RA. Histone phosphorylation and chromatin structure during mitosis in Chinese hamster cells. Eur J Biochem. 1978;84:1-15.
15. Kapur P, Rakheja D, Roy LC, Hoang MP. Fatty acid synthase expression in cutaneous melanocytic neoplasms. Mod Pathol. 2005;18:1107-1112.
16. Bowers DC, Gargan L, Kapur P, et al. Study of the MIB-1 labeling index as a predictor of tumor progression in pilocytic astrocytomas in children and adolescents. J Clin Oncol. 2003;21:2968-2973.
17. Ribalta T, McCutcheon IE, Aldape KD, Bruner JM, Fuller GN. The mitosis-specific antibody anti-phosphohistone-H3 (PHH3) facilitates rapid reliable grading of meningiomas according to WHO 2000 criteria. Am J Surg Pathol. 2004; 28:1532-1536.
18. Innocenzi D, Alo PL, Balzani A, et al. Fatty acid synthase expression in melanoma. J Cutan Pathol. 2003;30:23-28.
19. Davidson EJ, Morris LS, Scott IS, et al. Minichromosome maintenance (Mem) proteins, cyclin B1 and D1, phosphohistone H3 and in situ DNA replication for functional analysis of vulval intraepithelial neoplasia. Br J Cancer. 2003;88:257-262.
20. Scott IS, Heath TM, Morris LS, et al. A novel immunohistochemical method for estimating cell cycle phase distribution in ovarian serous neoplasms: implications for the histopathological assessment of paraffin-embedded specimens. Br J Cancer. 2004;90:1583-1590.
21. Xiong Y, Hannon GJ, Zhang H, Casso D, Kabayashi R, Beach D. P21 is a universal inhibitor of cyclin kinases. Nature. 1993;366:701-704.